BOSTON, May 4, 2026 /PRNewswire/ — Tune in live Tuesday, May 5 at 8:30 a.m. ET as IBM (NYSE: IBM) CEO Arvind Krishna opens IBM Think 2026 and explains how AI is becoming the defining force in business, what it takes to lead, and how quantum computing is emerging as the next frontier.
WHEN: Tuesday, May 5, 8:30 a.m. ET: https://www.ibm.com/events/think
Krishna will unveil his most comprehensive set of enterprise AI announcements to date, with new capabilities designed to help organizations move beyond pilots and put AI to work across the business. Drawing on IBM’s own transformation, Krishna will show how enterprises are embedding AI across operations, data, and decision making — and why hybrid cloud, AI, and quantum are converging into a new source of competitive advantage.
IBM’s flagship annual conference will bring together more than 5,000 senior business and technology leaders from over 80 countries to explore how organizations are putting agentic AI to work at scale. Sessions will cover agentic AI, hybrid cloud, trusted data, and automation, with a focus on real world deployments and measurable outcomes.
PHOTOS, VIDEO & TRANSCRIPTS AVAILABLE
Livestream keynotes throughout the week include:
WHO:
Client Speakers:
IBM Executive Speakers:
Sponsors:
WHERE: Thomas M. Menino Convention & Exhibition Center (MCEC), Boston, MA
CONTACT
Alexandra Prevor
IBM
Alexandra.Prevor@ibm.com
Logo – https://mma.prnewswire.com/media/2319830/IBM_LOGO_1.jpg
Logo – https://mma.prnewswire.com/media/2680004/Think_IBM.jpg
View original content:https://www.prnewswire.co.uk/news-releases/media-alert-ibm-ceo-arvind-krishna-to-open-ibm-think-2026-outlining-how-ai-and-quantum-will-define-the-enterprise-302761514.html
New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…
BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…
MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…
MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…
June 13, 2026 07:30 ET | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…